BridgeMD
New treatment option for Cervical Cancer
Official title Improving Diagnostics in Cervical Dysplasia
ClinicalTrials.gov ID: NCT05283421
What this study is testing
- What it's testing
- Cervical cancer is the fourth most common cancer in women worldwide. It is caused by an infection with human papillomavirus (HPV).
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older, women only
You may be able to join if
- Postmenopausal (defined as no bleeding ≥1 year) women referred for colposcopy aged ≥ 50 years.
- Women referred for colposcopy due to a positive HPV test and/or an abnormal cervical cytology.
- Women referred for colposcopy due to previous abnormal cervical histology with minimum 6. months since last colposcopy with biopsies.
You likely can't join if
- Use of estrogen within the last 3 months regardless of administration form.
- previous cervical radiotherapy, cervical amputation and/or cone biopsy
- pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Randers, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Randers, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.